Mauriello

Adamis Pharmaceuticals Stock Analysis ADMP

Long
NASDAQ:ADMP   None
The Idea is to go long as per Technical and Fundamental Analysis. Wait the possible end of the price set back before going long.
Shares of Adamis Pharmaceuticals Corporation ADMP surged 77.6% after it submitted an investigational new drug (IND) application to the FDA to begin a clinical study onTempol for thetreatment and prevention ofCOVID-19.
NASDAQ:ADMP

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.